Hua Xia Healthcare Holdings Limited provided earnings guidance for the three months ended December 31, 2013. The company expected to record a proportionately lowered profit attributable to the shareholders for the three months ended 31 December 2013 compared to that of the three months ended 31 December 2012, which is mainly due to the reduction of the company's equity interest in the pharmaceutical wholesale and pharmaceutical retail business operated under the Wanjia Group (from 100% to approximately 63.53% immediately upon completion of the Distribution on 10 October 2013) and in turn results in reduction of the profit attributable to the shareholders.